Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
CRMD
#2460
CorMedix Inc.
7.130
0
-1.79%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-1.79%
Monatliche Änderung
-8.24%
6 month change
-36.90%
Jahresänderung
-36.90%
Vorheriger Schlusskurs
7.260
0
Open
7.130
0
Bid
Ask
Low
7.130
0
High
7.130
0
Volumen
99
Märkte
Aktien
Gesundheitswesen
CRMD
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
60.68 M
65.18 M
67.82 M
74.65 M
78.79 M
—
Valuation ratios
Enterprise value
454.99 M
487.32 M
351.51 M
760.37 M
867.82 M
2.47 B
Price to earnings ratio
-10.1
-27
24.64
15.79
5.56
19
Price to sales ratio
38.71
10.97
4.72
6.68
4.07
26.44
Price to cash flow ratio
-8.18
-9.42
-21.6
32.79
12.04
13.81
Price to book ratio
1.93
5.63
1.26
1.72
1.11
9.71
Enterprise value to EBITDA ratio
-8.97
-22.1
23.39
15.2
7.75
24.24
Profitability ratios
Return on assets %
-0.04
0.11
0.14
0.08
0.14
0.47
Return on equity %
-0.05
0.16
0.18
0.09
0.29
0.72
Return on invested capital %
-146.64
221.48
225.66
223.32
142.32
812.79
Gross margin %
94.01
96.23
95.91
95.31
89.26
376.73
Operating margin %
-28.7
41.45
51.5
49.18
49.24
191.37
EBITDA margin %
-27.57
42.04
51.91
49.72
56.45
200.13
Net margin %
-24.24
43.14
52.82
49.9
104.11
249.97
Liquidity ratios
Quick ratio
3.6
3.16
3.99
7.52
1.73
16.4
Current ratio
3.96
3.39
4.21
7.82
1.94
17.36
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.17
0.32
0.29
0.2
0.21
1.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.39
—
Long term debt to total equity ratio
—
—
—
—
0.79
—
Per share metrics
Operating cash flow per share
-0.23
-0.1
0.29
0.42
0.36
0.97
EBIT per share
-0.06
0.22
0.29
0.27
0.64
1.42
EBITDA per share
-0.05
0.22
0.29
0.27
0.68
1.47
Total debt per share
—
—
—
—
—
—
Cash per share
0.78
0.88
1.12
2.65
0.65
5.3
Net current asset value per share
1.24
1.95
2.1
3.45
3.01
10.51
Tangible book value per share
0.97
1.41
1.64
3.04
-0.39
5.7
Working capital per share
0.93
1.37
1.6
3.01
1.46
7.44
Book value per share
1
1.44
1.67
3.07
4.34
10.51
Nachrichten
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?
Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?
CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?
CorMedix Inc. (CRMD) Analyst/Investor Day Transcript
CorMedix Inc. (CRMD) Analyst/Investor Day - Slideshow (NASDAQ:CRMD) 2026-02-11
CorMedix: Citizens bekräftigt hohes Kursziel und sieht Milliardenpotenzial bei REZZAYO
CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside
CorMedix stock rises after announcing $75 million share buyback plan
CorMedix startet Aktienrückkaufprogramm über 75 Millionen US-Dollar
CorMedix announces $75 million share repurchase program
CRMD Down 31% in a Month: Is This an Indication to Sell the Stock?